A detailed history of Birchview Capital, LP transactions in Accelerate Diagnostics, Inc stock. As of the latest transaction made, Birchview Capital, LP holds 325,239 shares of AXDX stock, worth $357,762. This represents 0.51% of its overall portfolio holdings.

Number of Shares
325,239
Previous 325,239 -0.0%
Holding current value
$357,762
Previous $380,000 46.32%
% of portfolio
0.51%
Previous 0.38%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.91 - $4.23 $91,000 - $423,000
100,000 Added 44.4%
325,239 $321,000
Q3 2023

Nov 14, 2023

SELL
$0.75 - $7.21 $1.52 Million - $14.6 Million
-2,027,149 Reduced 90.0%
225,239 $1.3 Million
Q3 2021

Nov 12, 2021

BUY
$5.31 - $8.25 $103,709 - $161,130
19,531 Added 0.87%
2,252,388 $13.1 Million
Q2 2021

Aug 10, 2021

BUY
$6.81 - $9.23 $133,006 - $180,271
19,531 Added 0.88%
2,232,857 $18 Million
Q1 2021

May 14, 2021

BUY
$7.99 - $15.0 $156,052 - $292,965
19,531 Added 0.89%
2,213,326 $18.4 Million
Q1 2020

May 12, 2020

BUY
$4.62 - $18.74 $46,200 - $187,399
10,000 Added 0.46%
2,193,795 $18.3 Million
Q3 2017

Nov 02, 2017

BUY
$21.1 - $25.15 $46.1 Million - $54.9 Million
2,183,795
2,183,795 $49 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $109M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.